By avoiding the digestive tract, IM injections can provide faster-acting results compared to oral supplements
Study: Triple-Hormone-Receptor Agonist Retatrutide for Obesity Journal: New England Journal of Medicine (NEJM) ClinicalTrials ID: NCT04881760 View Full Study Retatrutide is a glucagon, GLP-1, and GIP (triple hormone) receptor agonist being investigated to treat obesity
These infections are associated with adverse outcomes like human immunodeficiency virus (HIV) transmission risk, preterm birth, high susceptibility to infection of human papillomavirus (HPV), as well as higher probabilities of developing cervical, endometrial, and ovarian cancers as shown in Figure 1 (Ciberia et al., 2021)
The natural products magnolol and honokiol are positive allosteric modulators of both synaptic and extra-synaptic GABA(A) receptors
The compound provides 5-10 mg per week
PMID: 74